Pipeline
Oncology
DM5167
PARP1 target
Discovery
Lead Optimization
Preclinical
Phase I
Phase II
Phase III
-
Four cancer types with BRCA mutation and those with HRD
-
Blood-Brain Barrier (BBB) Permeable
-
Oral
Neurodegeneration
DM3159
TASR target
Discovery
Lead Optimization
Preclinical
Phase I
Phase II
Phase III
-
Alzheimer’s disease
-
Oral
DM3190
TASR target
Discovery
Lead Optimization
Preclinical
Phase I
Phase II
Phase III
-
Parkinson’s disease
-
Oral